Subject
Pharmacology,Immunology,Immunology and Allergy
Reference57 articles.
1. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review;Łukasiewicz;Cancers,2021
2. Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge;Nedeljković;Cells.,2019
3. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition;Hussain;Med. Oncol.,2021
4. Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer;Yousafzai;Am. J. Cancer Res.,2021
5. Wei Y, Guo Y, Zhou J, Dai K, Xu Q, Jin X. Nicotinamide overcomes doxorubicin resistance of breast cancer cells through deregulating SIRT1/Akt pathway. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2019; 19(5): 687-696.